ROYALTY PHARMA PLC

(RPRX)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 08-08-2022
43.13 USD   +1.60%
08/08ROYALTY PHARMA PLC : Morgan Stanley herhaalt koopadvies
MM
05/08ROYALTY PHARMA PLC : Goldman Sachs herhaalt koopadvies voor het aandeel
MM
04/08Royalty Pharma Q2 netto-inkomen, inkomsten dalen
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ROYALTY PHARMA PLC
04/08ROYALTY PHARMA PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
04/08Royalty Pharma Q2 Net Income, Revenue Decline
04/08TRANSCRIPT : Royalty Pharma plc, Q2 2022 Earnings Call, Aug 04, 2022
04/08ROYALTY PHARMA : Q2 Earnings Snapshot
04/08Earnings Flash (RPRX) ROYALTY PHARMA Reports Q2 Revenue $536M
04/08Morphosys wächst schwächer als von Analysten erwartet - Aktie dreht
04/08INSIDER SELL : Royalty Pharma
04/08Royalty Pharma Reports Second Quarter 2022 Results
04/08Royalty Pharma Reports Second Quarter 2022 Results
04/08Royalty Pharma plc Reports Earnings Results for the Second Quarter Ended June 30, 2022
01/08INSIDER SELL : Royalty Pharma
28/07INSIDER SELL : Royalty Pharma
28/07INSIDER SELL : Royalty Pharma
18/07Royalty pharma declares third quarter 2022 dividend
15/07Royalty Pharma Maintains Quarterly Dividend at $0.19; Payable Sep. 15 to Shareholders o..
15/07Royalty Pharma Declares Third Quarter 2022 Dividend
15/07Royalty Pharma Declares Third Quarter 2022 Dividend
15/07Royalty Pharma plc Declares Third Quarter 2022 Dividend, to Be Paid on September 15, 20..
14/07Royalty Pharma to Benefit From Unique Business Model, Expanding Market Opportunities, T..
14/07Wall Street Set to Extend Losses on Hot Inflation Report
14/07SECTOR UPDATE : Health Care Stocks Retreat Pre-Bell Thursday
14/07SECTOR UPDATE : Health Care
14/07Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022
14/07Royalty Pharma to Announce Second Quarter 2022 Financial Results on August 4, 2022
14/07Top Premarket Gainers
14/07Royalty pharma agrees to acquire royalty interest in trelegy ellipta from theravance an..
13/07Theravance to Sell Trelegy Ellipta Royalty Interests to Royalty Pharma; Shares Jump
13/07Innoviva Selling Minority Stake in Asthma Therapies Company; Shares Rising in After-Hou..
13/07ROYALTY PHARMA : AGREES TO ACQUIRE ROYALTY INTEREST IN TRELEGY ELLIPTA FROM THERAVANCE AND..
13/07ROYALTY PHARMA PLC : Other Events, Financial Statements and Exhibits (form 8-K)
13/07Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance an..
13/07Theravance Biopharma to Sell TRELEGY ELLIPTA Royalty Interests to Royalty Pharma for Ap..
01/07Cytokinetics Prices $450 Million Private Placement of Convertible Notes; Doubles Develo..
30/06Blueprint Medicines Secures $1.25 Billion Strategic Financing Via Partnerships with Roy..
30/06Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to ..
30/06Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to ..
30/06Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collabor..
30/06INSIDER SELL : Royalty Pharma
30/06Fitch Affirms Royalty Pharma at 'BBB-'; Outlook Stable
27/06Ipsen va lancer une OPA à 247 millions de dollars sur Epizyme, l'action reflue
24/06Royalty Pharma plc Announces Directorate Change
24/06ROYALTY PHARMA PLC(NASDAQGS : RPRX) dropped from Russell 1000 Growth Index
24/06ROYALTY PHARMA PLC(NASDAQGS : RPRX) dropped from Russell Midcap Growth Index
24/06ROYALTY PHARMA PLC(NASDAQGS : RPRX) dropped from Russell 3000E Growth Index
24/06ROYALTY PHARMA PLC(NASDAQGS : RPRX) dropped from Russell 3000 Growth Index
24/06ROYALTY PHARMA PLC(NASDAQGS : RPRX) dropped from Russell Small Cap Comp Growth Index
23/06ROYALTY PHARMA PLC : Submission of Matters to a Vote of Security Holders (form 8-K)
15/06Morphosys vergibt Lizenzen für zwei Antikörper-Medikamente an US-Firma
14/06TRANSCRIPT : Royalty Pharma plc Presents at Goldman Sachs 43rd Annual Global Healthcare Co..
13/06INSIDER SELL : Royalty Pharma
08/06Royalty Pharma to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
31/05INSIDER SELL : Royalty Pharma
25/05INSIDER SELL : Royalty Pharma
24/05TRANSCRIPT : Royalty Pharma plc Presents at UBS Global Healthcare Conference, May-24-2022 ..
23/05INSIDER SELL : Royalty Pharma
23/05INSIDER SELL : Royalty Pharma
23/05Royalty Pharma to Present at the UBS Global Healthcare Conference 2022
23/05Royalty Pharma to Present at the UBS Global Healthcare Conference 2022
18/05Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Uni..
17/05Royalty pharma announces charitable alliance with mount sinai
17/05TRANSCRIPT : Royalty Pharma plc - Analyst/Investor Day
17/05Royalty Pharma Sets New Capital Deployment Target
17/05ROYALTY PHARMA PLC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
17/05Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Uni..
17/05Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Uni..
11/05ROYALTY PHARMA PLC : Other Events (form 8-K)
05/05ROYALTY PHARMA PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
05/05TRANSCRIPT : Royalty Pharma plc, Q1 2022 Earnings Call, May 05, 2022
05/05Royalty Pharma Posts Lower Q1 Earnings, Revenue; Maintains 2022 Guidance
05/05ROYALTY PHARMA : Q1 Earnings Snapshot
05/05Earnings Flash (RPRX) RP MANAGEMENT LLC Posts Q1 Revenue $562M
05/05Royalty Pharma Reports First Quarter 2022 Results
05/05Royalty Pharma plc Reports Earnings Results for the First Quarter Ended March 31, 2022
05/05Morphosys intensiviert Forschung und macht mehr Verlust
04/05WDH/Morphosys intensiviert Forschung - Verluste steigen
1  2  3  4  5  6Volgende
Volgende evenement op ROYALTY PHARMA PLC